Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 20, 2023

BUY
$191.89 - $259.92 $43,175 - $58,482
225 New
225 $45,000
Q1 2022

Apr 25, 2022

SELL
$255.51 - $362.11 $2,810 - $3,983
-11 Closed
0 $0
Q3 2021

Nov 01, 2021

SELL
$372.64 - $458.3 $372 - $458
-1 Reduced 8.33%
11 $5,000
Q2 2021

Aug 02, 2021

BUY
$294.17 - $371.65 $3,530 - $4,459
12 New
12 $4,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track High Mark Wealth Management LLC Portfolio

Follow High Mark Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Mark Wealth Management LLC with notifications on news.